Frailty Prevention in Elders From Reunion Island (5P-PILOTE)

Frailty Prevention in Elderly People From Reunion Island: Effects of Adaptated Exercises on Physical Performance

In Reunion Island, people encounter environmental and social conditions leading to premature ageing and subsequent frailty. Social welfare has developped exercise programs to promote physical activity especially for elderly with higher risk factors of frailty, including low incomes.

The study evaluates the potent benefit effect of such exercise program on physical performance and frailty improvement in seniors from Reunion Island. All seniors participate to a 12-weeks exercise program especially dedicated to this targeted population needs and ability.

Study Overview

• Status: Completed
• Conditions: Physical Activity; Frail Elderly Syndrome
• Intervention / Treatment: Other: Exercise program

Detailed Description

Regular physical activity has been shown to slow down sarcopenia, and increase strengh in elders. Nevertheless, senior with low incomes do not usually have access to physical activity areas.

Social partners are in close relationship with these elders and could promote free exercise programs dedicated to elders classified as "GIR5-6" according to the French scale "AGIRR". The AGIRR scale takes into account several criteria allowing the evaluation of the level of autonomy. The level of autonomy is closely related to frailty and could be reversed since elders have not reach a dependant-state. The "GIR5-6" level means that elderly people are still not dependant but exhibit several frailty risk factors.

The level of frailty and the physical performance of the participants is assessed by standard geriatric evaluation before the 12-wks exercice program. The improvement of the physical performance is assessed after he 12-wks exercice program.

• Study Type: Interventional
• Enrollment (Actual): 97
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Réunion
  • Saint-joseph, Réunion
    • CHU Reunion Island

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 55 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Retired
• with an autonomy level corresponding to the "GIR 5-6" level of the French "AGIRR scale"
• informed consent

Exclusion Criteria:

• physical activity prohibited
• under guardianship

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Prevention
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Other: Exercise program; Participation to the 12-wks exercise program	Other: Exercise program; Measurement of physical performance before and after the 12 wks-exercice program

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Physical performance improvement	Physical performance is assessed as as balance, walk and strength improvement	Physical performance improvement from baseline to 12 wks

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Quality of life score	Improvement of quality of life assessed by SF36 v1 questionnaire	SF36 improvement from baseline to 12 wks

Collaborators and Investigators

• Sponsor: Centre Hospitalier Universitaire de la Réunion
• Collaborators: Institut de Recherche pour le Developpement; Centre National de la Recherche Scientifique, France; General Social Security Fund
• Investigators: Principal Investigator: Jean-Marc EYCHENE, MD, Centre Hpospitalier Universitaire de La REUNION

Study record dates

Study Major Dates

• Study Start (Actual): September 4, 2017
• Primary Completion (Actual): May 7, 2019
• Study Completion (Actual): July 4, 2019

Study Registration Dates

• First Submitted: August 31, 2017
• First Submitted That Met QC Criteria: August 31, 2017
• First Posted (Actual): September 1, 2017

Study Record Updates

• Last Update Posted (Actual): March 4, 2020
• Last Update Submitted That Met QC Criteria: March 3, 2020
• Last Verified: March 1, 2020

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Pathologic Processes; Frailty
• Other Study ID Numbers: 2017/CHU/00

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No